Mirador Capital Partners LP Celldex Therapeutics, Inc. Transaction History

Mirador Capital Partners LP

$597 Million
Q2 2025

A detailed history of Mirador Capital Partners LP transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Mirador Capital Partners LP holds 158,717 shares of CLDX stock, worth $3.56 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

158,717

Previous 127,874 24.12%

Holding current value

$3.56 Million

Previous $2.55 Million 26.73%

% of portfolio

0.54%

Previous 0.48%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 09, 2025	BUY	$15.13 - $21.65 $466,654 - $667,750	30,843 Added 24.12%	158,717 $3.23 Million
Q1 2025 Apr 08, 2025	BUY	$18.15 - $27.6 $152,133 - $231,343	8,382 Added 7.01%	127,874 $2.55 Million
Q4 2024 Jan 14, 2025	BUY	$23.31 - $32.4 $77,971 - $108,378	3,345 Added 2.88%	119,492 $3.02 Million
Q3 2024 Oct 04, 2024	BUY	$32.06 - $44.56 $120,802 - $167,902	3,768 Added 3.35%	116,147 $3.95 Million
Q2 2024 Jul 12, 2024	BUY	$32.76 - $42.56 $249,631 - $324,307	7,620 Added 7.27%	112,379 $4.16 Million
Q1 2024 Apr 17, 2024	SELL	$35.22 - $51.88 $110,978 - $163,473	-3,151 Reduced 2.92%	104,759 $4.4 Million
Q4 2023 Jan 19, 2024	BUY	$22.61 - $40.65 $2,080 - $3,739	92 Added 0.09%	107,910 $4.28 Million
Q3 2023 Oct 05, 2023	BUY	$25.45 - $37.46 $78,971 - $116,238	3,103 Added 2.96%	107,818 $2.97 Million
Q2 2023 Aug 14, 2023	BUY	$30.29 - $38.28 $115,889 - $146,459	3,826 Added 3.79%	104,715 $3.55 Million
Q1 2023 Apr 14, 2023	SELL	$34.78 - $47.43 $162,387 - $221,450	-4,669 Reduced 4.42%	100,889 $3.63 Million
Q4 2022 Feb 09, 2023	SELL	$27.78 - $45.38 $43,614 - $71,246	-1,570 Reduced 1.47%	105,558 $4.7 Million
Q3 2022 Nov 14, 2022	BUY	$22.7 - $37.57 $17,252 - $28,553	760 Added 0.71%	107,128 $3.01 Million
Q2 2022 Aug 05, 2022	BUY	$20.5 - $37.33 $334,560 - $609,225	16,320 Added 18.12%	106,368 $2.87 Million
Q1 2022 May 06, 2022	BUY	$27.64 - $39.32 $110,449 - $157,122	3,996 Added 4.64%	90,048 $3.07 Million
Q4 2021 Feb 02, 2022	BUY	$35.68 - $56.27 $440,148 - $694,146	12,336 Added 16.73%	86,052 $3.33 Million
Q3 2021 Nov 09, 2021	SELL	$28.95 - $55.99 $143,678 - $277,878	-4,963 Reduced 6.31%	73,716 $3.98 Million
Q2 2021 Jul 27, 2021	BUY	$20.71 - $35.37 $62,192 - $106,216	3,003 Added 3.97%	78,679 $2.63 Million
Q1 2021 Apr 29, 2021	BUY	$16.19 - $29.91 $792,128 - $1.46 Million	48,927 Added 182.91%	75,676 $1.56 Million
Q4 2020 Jan 20, 2021	BUY	$14.99 - $22.75 $19,232 - $29,188	1,283 Added 5.04%	26,749 $469,000
Q3 2020 Nov 12, 2020	BUY	$9.65 - $15.19 $61,103 - $96,183	6,332 Added 33.09%	25,466 $378,000
Q2 2020 Aug 06, 2020	BUY	$1.61 - $13.41 $12,561 - $104,624	7,802 Added 68.85%	19,134 $249,000
Q1 2020 May 11, 2020	BUY	$1.55 - $3.07 $17,564 - $34,789	11,332 New	11,332 $27,000

Others Institutions Holding CLDX

# of Institutions

189

Shares Held

69.4M

Call Options Held

220K

Put Options Held

310K

View Full List

About Celldex Therapeutics, Inc.

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.05B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

More about CLDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirador Capital Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Mirador Capital Partners LP with notifications on news.

Account

Mirador Capital Partners LP Celldex Therapeutics, Inc. Transaction History